SDHB-related pheochromocytoma and paraganglioma penetrance and genotype–phenotype correlations-Reference-Cited by-同舟云学术

SDHB-related pheochromocytoma and paraganglioma penetrance and genotype–phenotype correlations

Published:2017-04-03 Issue:8 Volume:143 Page:1421-1435
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Jochmanova Ivana,Wolf Katherine I.,King Kathryn S.,Nambuba Joan,Wesley Robert,Martucci Victoria,Raygada Margarita,Adams Karen T.,Prodanov Tamara,Fojo Antonio Tito,Lazurova Ivica,Pacak Karel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2397-3/fulltext.html

Reference46 articles.

1. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812–8818. doi: 10.1200/JCO.2005.03.1484

2. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, Plouin PF (2007) Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92:3822–3828. doi: 10.1210/jc.2007-0709

3. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE (2003) Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 113:228–237

4. Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C (2012) Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer 118:2804–2812. doi: 10.1002/cncr.26577

5. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG (2006) Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91:827–836. doi: 10.1210/jc.2005-1862

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal and Cell Culture Models of PPGLs – Achievements and Limitations;Hormone and Metabolic Research;2024-01

2. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement;Nature Reviews Endocrinology;2023-12-14

3. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma;Frontiers in Endocrinology;2023-12-13

4. Research progress on the pathogenesis of the SDHB mutation and related diseases;Biomedicine & Pharmacotherapy;2023-11

5. Retroperitoneal Paraganglioma Treated With Tumor Resection and Replacement of the Inferior Vena Cava;Cureus;2023-10-16